Compare the effects of ketofol alone and ketofol with dexmedetomidine in modified electroconvulsive therapy
Not Applicable
- Registration Number
- CTRI/2022/05/042768
- Lead Sponsor
- JLN medical college and hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients between the age group of 18 to 60 years of either sex under going modified ECT.
2.Patients belonging to ASA I and II grades.
3.¬Informed written consent.
Exclusion Criteria
1.Patient age below then 18yrs and more then 60yrs.
2.ASA III,IV,V status;
3.Hypersensitivity to any study drug;
4.History of any serious physical disease, such as cardiovascular disease; cerebrovascular disorder, respiratory tract disease, and severe fracture;
5.Glaucoma;
6.History of seizures and those using anticonvulsant drugs;
7.History of substance abuse or dependence, including alcohol abuse;
8.Presence of a foreign body, such as a pacemaker;
9.Pregnancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method to increase the duration of seizure activityTimepoint: Around 1 year
- Secondary Outcome Measures
Name Time Method 1.Hemodynamic changes <br/ ><br>2.Recovery Time <br/ ><br>3.Post agitation score <br/ ><br>4.Adverse effect if any <br/ ><br>Timepoint: till patient recover